| Meniett device for Ménière's disease: use and compliance at 3 to 5 years. | |
| | |
MedLine Citation:
|
PMID: 18199955 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To review the continued use of the Meniett device 2 and 3 years after the device's initial prescription. STUDY DESIGN: Retrospective case series. SETTING: Tertiary referral center. PATIENTS: Patients fitting American Academy of Otolaryngology-Head and Neck Surgery criteria for Ménière's disease who had failed conventional medical therapy between February 2002 and April 2004 and who were ready for surgical intervention. INTERVENTION: Patients used the Meniett device as a nonsurgical alternative for Ménière's management. OUTCOME MEASURES: Continued use or non-use of the device. RESULTS: Twenty-three patients were prescribed and obtained the Meniett device in the study interval. At 2 years of minimum follow-up, there were 21 evaluable patients. Eleven patients (52%) continued to use the device and have good control of vertiginous symptoms at 2+ years. Four patients (19%) were asymptomatic at 1 year and discontinued the use of the device. Six patients (29%) had no impact on their Ménière's symptoms and stopped using the device within the first 3 months. At 3 years of minimum follow-up, there were 19 evaluable patients; of whom, 63% were either using the device or had become asymptomatic. No complications were attributable to the device. CONCLUSION: We conclude that the Meniett device is a useful minimally invasive alternative in the management of Ménière's disease. Among these patients who had failed previous medical management, 71% and 63% required no additional intervention beyond the Meniett device at a minimum of 2 and 3 years of follow-up, respectively. Most patients who failed to gain benefit did so early on in therapy. |
| | |
Authors:
|
Douglas E Mattox; Mary Reichert |
Related Documents
:
|
2263515 - A trial with a new peripheral implanted vascular access device. 12047405 - The antibiotic-lock technique for therapy of 'highly needed' infected catheters. 8206405 - Intraperitoneal therapy administered through a groshong catheter. 1874025 - Balloon dilation treatment of phimosis in boys. report of 512 cases. 11069195 - Predicting subsequent bone density response to intermittent cyclical therapy with etidr... 19291745 - Complications of fractional co2 laser resurfacing: four cases. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology Volume: 29 ISSN: 1531-7129 ISO Abbreviation: Otol. Neurotol. Publication Date: 2008 Jan |
Date Detail:
|
Created Date: 2008-01-17 Completed Date: 2008-02-25 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100961504 Medline TA: Otol Neurotol Country: United States |
Other Details:
|
Languages: eng Pagination: 29-32 Citation Subset: IM |
Affiliation:
|
Department of Otolaryngology-Head and Neck Surgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA. douglas.mattox@emoryhealthcare.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cochlear Implants*
/
adverse effects Cohort Studies Endpoint Determination Equipment Failure Follow-Up Studies Humans Meniere Disease / therapy* Otitis Media / etiology Patient Compliance Recurrence Retrospective Studies Treatment Failure |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Congenital absence of the oval window: diagnosis, surgery, and audiometric outcomes.
Next Document: Longitudinal results with intratympanic dexamethasone in the treatment of Ménière's disease.